NRx Pharmaceuticals, Inc. (NRXP)

NRx Pharmaceuticals Statistics

Total Valuation

NRXP has a market cap or net worth of $34.51 million. The enterprise value is $39.32 million.

Market Cap	34.51M
Enterprise Value	39.32M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, after market close.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

NRXP has 16.92 million shares outstanding. The number of shares has increased by 40.50% in one year.

Current Share Class	16.92M
Shares Outstanding	16.92M
Shares Change (YoY)	+40.50%
Shares Change (QoQ)	+11.64%
Owned by Insiders (%)	10.54%
Owned by Institutions (%)	6.23%
Float	14.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-1.49
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.15

Current Ratio	0.15
Quick Ratio	0.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-85.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-224.60%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	108.19%
Revenue Per Employee	n/a
Profits Per Employee	-$12.56M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.66% in the last 52 weeks. The beta is 1.45, so NRXP's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	-27.66%
50-Day Moving Average	2.03
200-Day Moving Average	2.00
Relative Strength Index (RSI)	51.01
Average Volume (20 Days)	107,000

Short Selling Information

The latest short interest is 1.24 million, so 7.36% of the outstanding shares have been sold short.

Short Interest	1.24M
Short Previous Month	1.30M
Short % of Shares Out	7.36%
Short % of Float	8.78%
Short Ratio (days to cover)	6.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.70M
Pretax Income	-25.64M
Net Income	-25.13M
EBITDA	-19.70M
EBIT	-19.70M
Earnings Per Share (EPS)	-$2.36

Balance Sheet

The company has $1.44 million in cash and $6.26 million in debt, giving a net cash position of -$4.81 million or -$0.28 per share.

Cash & Cash Equivalents	1.44M
Total Debt	6.26M
Net Cash	-4.81M
Net Cash Per Share	-$0.28
Equity (Book Value)	-23.22M
Book Value Per Share	-1.59
Working Capital	-18.56M

Cash Flow

Operating Cash Flow	-10.64M
Capital Expenditures	n/a
Free Cash Flow	-10.64M
FCF Per Share	-$0.63

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-40.50%
Shareholder Yield	-40.50%
Earnings Yield	-72.81%
FCF Yield	-30.82%

Analyst Forecast

The average price target for NRXP is $28.50, which is 1,297.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.50
Price Target Difference	1,297.06%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on April 2, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Apr 2, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1